Development of a New Remote Monitoring Model for Patients With HR+HER2- Breast Cancer in Treatment With CDK4/6 Inhibitors and Hormone Therapy
Conditions
- Breast Cancer
- CDK4/6 Inhibitor
Interventions
- OTHER: Home questionnaire
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS